Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 3
1956 9
1957 10
1958 9
1959 8
1960 9
1961 7
1962 8
1963 22
1964 34
1965 21
1966 18
1967 33
1968 34
1969 32
1970 34
1971 40
1972 42
1973 36
1974 43
1975 32
1976 32
1977 44
1978 55
1979 69
1980 92
1981 125
1982 123
1983 128
1984 179
1985 202
1986 215
1987 250
1988 241
1989 276
1990 305
1991 307
1992 349
1993 367
1994 367
1995 441
1996 511
1997 550
1998 613
1999 724
2000 736
2001 748
2002 733
2003 780
2004 820
2005 876
2006 973
2007 1001
2008 1100
2009 1124
2010 1208
2011 1236
2012 1447
2013 1613
2014 1707
2015 1631
2016 1743
2017 1828
2018 1907
2019 1978
2020 2265
2021 2253
2022 2263
2023 558
Text availability
Article attribute
Article type
Publication date

Search Results

36,352 results
Results by year
Filters applied: . Clear all
Page 1
Renaissance of vancomycin: approaches for breaking antibiotic resistance in multidrug-resistant bacteria.
Mühlberg E, Umstätter F, Kleist C, Domhan C, Mier W, Uhl P. Mühlberg E, et al. Can J Microbiol. 2020 Jan;66(1):11-16. doi: 10.1139/cjm-2019-0309. Epub 2019 Sep 23. Can J Microbiol. 2020. PMID: 31545906 Free article. Review.
Since the discovery of the first vancomycin-resistant enterococci strains in the late 1980s, the number of resistances has been steadily rising, with often life-threatening consequences. As an alternative to the generation of completely new substances, novel approaches foc …
Since the discovery of the first vancomycin-resistant enterococci strains in the late 1980s, the number of resistances has been stead …
Vancomycin.
Wilhelm MP. Wilhelm MP. Mayo Clin Proc. 1991 Nov;66(11):1165-70. doi: 10.1016/s0025-6196(12)65799-1. Mayo Clin Proc. 1991. PMID: 1943250 Review.
Vancomycin is bactericidal against most strains of staphylococci and nonenterococcal streptococci. Although rare strains of staphylococci and enterococci that are resistant to vancomycin have been reported, bacterial resistance has thus far not emerged as a major cl …
Vancomycin is bactericidal against most strains of staphylococci and nonenterococcal streptococci. Although rare strains of staphyloc …
The pharmacokinetic and pharmacodynamic properties of vancomycin.
Rybak MJ. Rybak MJ. Clin Infect Dis. 2006 Jan 1;42 Suppl 1:S35-9. doi: 10.1086/491712. Clin Infect Dis. 2006. PMID: 16323118 Review.
Therefore, understanding the clinical implications of the pharmacokinetic and pharmacodynamic properties of vancomycin is a necessity for clinicians. Vancomycin is a concentration-independent antibiotic (also referred to as a "time-dependent" antibiotic), and there …
Therefore, understanding the clinical implications of the pharmacokinetic and pharmacodynamic properties of vancomycin is a necessity …
Vancomycin: a history.
Levine DP. Levine DP. Clin Infect Dis. 2006 Jan 1;42 Suppl 1:S5-12. doi: 10.1086/491709. Clin Infect Dis. 2006. PMID: 16323120
In addition, resistance to vancomycin developed, first in enterococci and later in staphylococci. ...The findings of future studies may result in a return to measuring levels of vancomycin in serum, to assure a successful therapeutic outcome....
In addition, resistance to vancomycin developed, first in enterococci and later in staphylococci. ...The findings of future studies m …
A Moving Target-Vancomycin Therapeutic Monitoring.
Burns AN, Goldman JL. Burns AN, et al. J Pediatric Infect Dis Soc. 2020 Sep 17;9(4):474-478. doi: 10.1093/jpids/piaa078. J Pediatric Infect Dis Soc. 2020. PMID: 32716487 Review.
Therapeutic drug monitoring (TDM) has been a common practice to optimize efficacy and safety of vancomycin. While vancomycin trough-only TDM has widely been integrated into pediatric clinical practice since 2009, recently updated vancomycin TDM guidelines pub …
Therapeutic drug monitoring (TDM) has been a common practice to optimize efficacy and safety of vancomycin. While vancomycin t …
Vancomycin: The pendulum swings.
Scheetz MH. Scheetz MH. Am J Health Syst Pharm. 2020 May 19;77(11):810-811. doi: 10.1093/ajhp/zxaa076. Am J Health Syst Pharm. 2020. PMID: 32426842 No abstract available.
Vancomycin.
Cunha BA. Cunha BA. Med Clin North Am. 1995 Jul;79(4):817-31. doi: 10.1016/s0025-7125(16)30041-4. Med Clin North Am. 1995. PMID: 7791425 Free article. Review.
Vancomycin should not be added to drug regimens for gram-positive coverage, and the empiric use of vancomycin should be discouraged to avoid the emergence of VRE. Vancomycin serum levels are no longer necessary or cost effective in most patients because va …
Vancomycin should not be added to drug regimens for gram-positive coverage, and the empiric use of vancomycin should be discou …
Vancomycin.
Geraci JE, Hermans PE. Geraci JE, et al. Mayo Clin Proc. 1983 Feb;58(2):88-91. Mayo Clin Proc. 1983. PMID: 6823162
Vancomycin is a narrow-spectrum bactericidal antistaphylococcal antibiotic that was introduced in 1956 because of its efficacy against resistant penicillinase-producing staphylococci. ...When methicillin and the other semisynthetic penicillins and the cephalosporins were i …
Vancomycin is a narrow-spectrum bactericidal antistaphylococcal antibiotic that was introduced in 1956 because of its efficacy agains …
Vancomycin.
Hermans PE, Wilhelm MP. Hermans PE, et al. Mayo Clin Proc. 1987 Oct;62(10):901-5. doi: 10.1016/s0025-6196(12)65046-0. Mayo Clin Proc. 1987. PMID: 3657307
Vancomycin is a narrow-spectrum bactericidal antibiotic used primarily for treatment of serious staphylococcal infections. ...The major toxic effect associated with the use of vancomycin is ototoxicity, which may develop when serum levels exceed 30 micrograms/ml....
Vancomycin is a narrow-spectrum bactericidal antibiotic used primarily for treatment of serious staphylococcal infections. ...The maj …
Vancomycin.
Fekety R. Fekety R. Med Clin North Am. 1982 Jan;66(1):175-181. doi: 10.1016/s0025-7125(16)31451-1. Med Clin North Am. 1982. PMID: 7038327 Review.
Used properly, vancomycin appears efficacious and can be given with safety to infants, children, and adults. Vancomycin is incompatible with many other drugs in intravenous solutions, especially chloramphenicol, adrenocorticosteroids, and methicillin....
Used properly, vancomycin appears efficacious and can be given with safety to infants, children, and adults. Vancomycin is inc …
36,352 results
You have reached the last available page of results. Please see the User Guide for more information.